Graphiti – fast (<1h) phenotypic AST

Bringing fast (1h) phenotypic AST using patented graphene sensing technology

Save time and lives. Perform fast and highly parallelized AST on single cell level.

Technology:
  • Antimicrobial stewardship
  • Microbial diagnostics
  • Infection prevention
  • Antimicrobial compound/strategy
  • Removal antibiotics/bacteria

Microorganisms:
  • Bacteria
  • Viruses
  • Fungi
  • Yeasts
  • Parasites

Application:
  • Human
  • Veterinary
  • AgriFood
  • Environmental
  • Other

Development stage:
  • Development
  • Research
  • Validation
  • Market entry
  • Marketed product

Organization:
  • Academia
  • Company
  • Institute
  • NGO
  • Government

Partnering:
  • License
  • Co-develop
  • Outsource
  • Joint Venture
  • Sell

Funding organisation:
  • OTHER / NA
  • CARB-X
  • FIND
  • GARDP
  • REPAIR

Infectious disease area:
  • UTI
  • BSI
  • RTI
  • GII
  • CNSI
  • IAI
  • SSI
  • STI
  • SSTI

Geographic origin:
  • Eurasia
  • North America
  • South America
  • Africa
  • Oceania


Looking for partners that can help validate and build our technology and business.

Graphiti is a pre start-up initiative aiming to bring fast (<1h) phenotypic Antimicrobial Susceptibility testing

Able to provide research services to (academic) hospitals, pharma discovery projects and diagnostic centers.


What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed